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Summary.-Anti-inflammatory corticosteroids administered to rats in high dosages
before intravenous injection of allogeneic tumour cells caused 5-10 fold reductions
in "take" and clonogenic growth of the cells in lung and kidney and decreased
growth and spread of the cells transplanted to leg muscle. Steroid therapy also
reduced the effect of local irradiation of lung tissues in increasing tumour colony
efficiency (CFE) in the lungs; it also tended to reduce similar effects of sublethal
whole body irradiation. A non-steroidal anti-inflammatory drug, phenylbutazone,
also reduced CFE in locally irradiated lungs in the rat.
The results obtained indicate that corticosteroids do not stimulate the growth of
implanted tumour cells by suppressing host immunity but decrease their clonogenic
growth by inhibiting local inflammatory reactions to cell arrest, and similarly to
local tissue damage caused by x-irradiation; it is asserted that such inflammatory
reactions are growth promoting and thereby stimulate regeneration of stroma
(repair) and also support survival and early growth of the tumour cell.
FOLLQWING intravenous injection into
rats of cells of the allogeneic tumours
W-256 and Y-P388, the colony forming
efficiency (CFE) of the cells in lungs has
been shown to decrease with increasing
age of the recipients, even after sublethal
whole body irradiation was given shortly
before the injection of tumour cells to
suppress immunity to their growth (van
den Brenk, Sharpington and Orton,
1973a). CFE in the lungs was also
increased (irrespective of host age) by
local irradiation of the lungs if the irradi-
ation was given at least 5-7 days before
injection of tumour cells (van den Brenk
et al., 1973b). CFE in liver and kidney
also were similarly increased by prior
local irradiation of these organs (van den
Brenk and Kelly, 1973). Although the
tumours used in these experiments induce
an immune response in the hosts, reasons
have been given why this feature does not
explain the effects of age and local irradia-
tion on CFE, which we have attributed
to ecological changes affecting the avail-
ability of tumour growth stimulating
substances at the site of tumour cell
arrest.
In this paper we report the inhibitory
effect of anti-inflammatory corticosteroids
on primary intramuscular implants and
their nodal metastases, and on the CFE
in lung of intravenously injected cells of
the same tumours.
MATERIALS AND METHODS
Sublines of the Yoshida and Walker rat
tumours (designated Y-P388 and W-256
respectively) and Caworth Farm Strain SPF
rats were used in the experiments.
We have described previously (van den
Brenk, Moore andSharpington, 1971; van den
Brenk et al., 1973a, b) the preparation of
single-cell suspensions from the tumours,
exposure of rats to whole body irradiation
(WBI) or to local thoracic irradiation (LTI),
the method of determining CFE from counts
of tumour cell colonies in the lungs and
kidneys, and the measurements ofthe growthH. A. S. VAN DEN BRENK, H. KELLY AND C. ORTON
of primary tumour implants in leg muscle
and of secondary tumours produced by the
implants in lymph nodes or lungs.
The compounds used were cortisone ace-
tate (Cortisyl; Roussel Laboratories Ltd), hy-
drocortisone sodium succinate (Organon
Laboratories Ltd), dexamethasone sodium
phosphate (Decadron; Merck, Sharp and
Dohme Ltd), mepyramine maleate (Anthisan;
May and Baker Ltd) and phenylbutazone
(Butazolidin; Geigy U.K. Ltd). These com-
pounds were injected intramuscularly in
dosages to be described.
The results of the experiments were
assessed 7 days after intravenous injection
of tumour cells, when the rats were weighed
and killed by an overdose of pentobarbitone
sodium; the lungs, thymus and spleen were
weighed and their weights expressed in
terms of organ weight per unit final body
weight; tumour colonies in lungs and kidneys
were also counted.
W-256 and Y-P388 tumours are heavily
laden with blood and their growth produces
progressive anaemia. Anticoagulant therapy
and exsanguination ofthe animal, followed by
arterial perfusion of the circulation with
saline fails to remove most of this blood from
the tumour (van den Brenk et al., 1972).
The amount of blood present in a tumour
contributes to its weight and may be selec-
tively affected by a particular treatment for
reasons which may not be clear. Conse-
quently, in one experiment the tissue haemo-
globin concentration in the primary implant
and in metastases of regional lymph nodes
was measured. The rats were deeply anaes-
thetized with pentobarbitone sodium and
exsanguinated; the primary tumour (Pr)
and metastases in pelvic lymph nodes (PN)
were removed and weighed; these tissues
were then finely minced and extracted over-
night in ice-cold 0.1% ammonium hydroxide.
The haemoglobin in the filtered extract was
measured photometrically as described by
Marshall (1971).
RESULTS
Effect of WBI and corticosteroids on CFE
In 10-week old rats, neither sublethal
WBI nor a single large dose of cortisone
caused a significant alteration in CFE in
lungs and kidneys of rats injected intra-
venously with Y-P388 cells 0-24 h later;
combined treatment with WBI and corti-
sone, or a larger dose of WBI, were also
ineffective (Table I). Thus, as reported
previously (van den Brenk et al., 1973a),
immunosuppression by the largest dose
of WBI (570 rad), found to be sublethal
under the conditions ofthese experiments,
was ineffective in increasing clonogenic
growth of allogeneic tumour cells in 10-
week old rats-an age when CFE already
is greatly reduced. When 2 large doses
of hydrocortisone or dexamethasone were
combined with WBI, no statistically
significant changes in CFE were produced
by hydrocortisone in immunosuppressed
rats (Table II). The more potent anti-
inflammatory steroid, dexamethasone,
reduced CFE in both lungs and kidneys,
but the high dosage used caused marked
loss of body weight of rats, which may
TABLE I. -Effect of Whole Body Irradiation (WBI) and a Single Dose of 15 mg Cortisone
Acetate per kg Body Weight on CFE in Lungs and Kidney of 10-week old Female Rats
Injected Intravenously with 103 Y-P388 Tumour Cells (Day 0) and Killed 7 Days
Later (6 Rats per Group)
Treatment
Nil
Cortisone (Day 0)
570 rad WBI (Day- 1)
570 rad WBI (Day 1)
plus
Cortisone (Day 0)
285 rad WBI (Day -2)
plus
570 rad WBI (Day - 1)
AW
+20±3
+ 15±3
+5±4
NL
7±4
9±5
12±7
NK
0-240-2
0.0
0* 7±0*3
wsp
0 * 234
0 212
0-195
Wth
0110
0*090
0 089
W L
0 634
0 627
0 612
+4±2 12±3 1*3±0-6 0-213 0-080 0 713
-2±5 13±6 0 7±0 3 0-143 0 037 0-664
Abbreviations: AW (g) increase in body weight (Day 0 to Day 7); NL and NK mean numbers (±s.e.) of lung and kidney tumour colonies per rat; wsp, Wth and WL weights of spleen, thymus and lungs expressed
as g/100 g body weight.
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TABLE II.-Effect of Two Doses of Compounds* given on Day -2 and Day -1 on
Production ofLung and Kidney Tumour Colonies in 5-week oldFemale Rats given 570
rad WBI (Day -1) and Injected Intravenously with 5 X 102 or 5 X 103 Y-P388
Cells on Day 0 (6 Rats per Group)
5x 102 cells
A_
Treatment AW NL NK
Saline +19 14+3 0-7±0-2
Mepyramine +21 14+2 1-2+04
Dexamethasone -12 7±2 0*3+0* 2
Hydrocortisone +11 17±3 2*3+0* 7
5 x 103 cells
/\W NL NK
+20 71+6 6-2±0-9
+23 86±11 6*2+1*9
-16 50±5 1*8+0-3
+5 117+15 9-3+1-4
* Dose per injection: mepyramine maleate (50 mg/kg), dexamethasone (25 mg/kg), hydrocortisone
(25 mg/kg).
TABLE III.-Effect of 3 Doses of Dexamethasone or Cortisone on Days -3, -2 and -1
in 6-week old Female Rats given 570 rad WBI (Day -1) on Number of Lung and
Kidney Colonies Produced by 3 X 103 Y-P388 Cells Injected Intravenously on Day 0
(8 Rats per Group)
Treatment
Saline
Dexamethasone
5 mg/kg
10 mg/kg
Cortisone
5 mg/kg
10 mg/kg
AW
+24±1
+12+1
+6+1
have reduced the survival and growth of
tumour cells. Large doses of an anti-
histamine (mepyramine maleate) did not
effect CFE or growth of rats. When the
dosage of dexamethasone was reduced to
a level at which there was less effect on
growth of rats, CFE of Y-P388 cells in
lung and kidney of immunosuppressed
rats was not affected (Table III).
It is concluded that corticosteroids
with a predominantly anti-inflammatory
action did not decrease resistance to clono-
genic growth of allogeneic tumour cells
in the rat, or increase any immunosup-
pressive effects WBI might have on
tumour growth in mature animals, as
judged by their failure to increase CFE.
Similar results were obtained when CFE
was measured for W-256 cells in immuno-
suppressed weanling rats (see below).
Effect of corticosteroids on stimulation of
CFE by LTI
It has been shown that 7-14 days
after local irradiation of the lung, kidney
or liver with 1000-1500 rad x-rays, CFE
NL
64+8
NK
2-6+0-6
65+9 3 9+0 8
63+6 3-7+0 7
73+11 4-6+1*2
101+38 7-0+1-4
of Y-P388 and W-256 tumour cells was
greatly increased (van den Brenk et al.,
1973b; van den Brenk and Kelly, 1973).
The effect on CFE of administering corti-
costeroids during the interval between
local irradiation of the lungs and intra-
venous injection of W-256 tumour cells
was examined, steroid treatment being
discontinued 48 h before injection of the
tumour cells. Dexamethasone (5 mg/kg
body weight) given daily for 4 days
reduced CFE in lungs of both unirradiated
and irradiated rats (Table IV and Fig. 1).
This effect of steroid treatments could not
be attributed to an effect on body growth;
it appears to be due to an effect of the
steroid on local reactions causing resist-
ance of the lungs to tumour growth-a
resistance which is decreased by local
x-irradiation oflung tissue. The decrease
in tumour CFE produced by large doses
of dexamethasone in rats given WBI
(Table II) may be due to similar causes,
i.e. a suppression of radiation reactions in
the tumour bed which decreases natural
resistance to tumour growth.
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TABLE IV. Effect of 5 mg Dexamnethasone (DMZ) per kg Body Weight Injected Dailyfor
4 Days (Days -5, -4, -3, 2) before Intravenous Injection of W-256 cells (on Day
0), on Number of Lung Colonies (NL) Produced in Unirradiated Rats, or in Rats given
1000 rad Local Thoracic Irradiation (LTI) on Day -7. AW (g) represents Increase in
Body Weight over 14 days from Day -7, to +7 (8 six-week old Female Rats per
Group)
Number of tumour cells
injected (N)
103
2-5 x 103
5 x 103
104
Treatment
LTI DMVZ
+_
+
+±
+ +
± +
+_
+ +
In weanling (3-week old) rats, WRBI
markedly increased CFE in lungs follow-
ing intravenous injection of allogeneic
tumour cells, whereas it had little effect
in this respect when rats were 5 weeks old;
N
',3
iv
2
I0
4 10 10
Ir-
. T1
FIF. 1.-Number of lunig colonies (N L)
plotted against number of W-256 cells (N)
injected intravenously in rats, from data in
Table IV. LTI only; O LTI plus DMZ,
* no treatment, L- DMZ only.
in weanlings WBI was more effective than
LTI (van den Brenk et al., 1973a). How-
ever, whereas dexamethasone decreased
CFE in weanlings given LTI, it had no
significant effect on CFE in weanlings
given WBI (Table V7), although it caused
similar marked reductions in body weight
and in weight of the thymus in rats given
LTI or WIBI.
It has been shown that the relationship
between number of lung tumour colonies
(AL) and the number of tumour cells (N)
injected intravenously can be expressed
as:
NL kNO
where k and 0 are constants (van den
Brenk et al., 1973a). Applying this
relationship to the data in Table IV
(represented graphically in Fig. 1), the
values for k and 0 are:
k 0
LTI 0-153 0- 79
LTIplu8DAMZ 0* 0075 1*01
Since the lines for the 2 treatments
have different slopes, they would be
expected to intersect with increase in N,
assuming the relationship to be linear
throughout; the effect of DMZ in reducing
the effect of LTI on CFE would be
expected to disappear when 106 W-256
cells are injected intravenously. Also,
it can be calculated that -1 7 cells are
required to produce a single lung colony
AW
(g)
+59 ±2
+31±2
+48±4
+30± 2
+57±3
+-34 2
+71 3
+37 - 2
+48-+3
+37+ 1
L
39-4-5
81-- 1
884-19
18-i- 8
125± 2()
51±16
10+ 3
1 0-8
> 200
85 422
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TABLE V.-Effect of 10 mg Dexamethasone per kg Body Weight Injected Intramuscularly
Daily for 4 days* preceding Intravenous Injection of Weanling Female Rats with
3 X 102 W-256 Cells on Growth of Lung Tumour Colonies. When Rats were 3 weeks
old, 7 days before the Injection of Cells, Rats in Groups A and B were given 570 rad
Whole Body Irradiation (WBI) and Rats in C and D 1000 rad Local Thoracic Irradia-
tion (LTI). W1 Mean Body Weight at Time of Irradiation, W2 Final Mean Body
Weight (8 Rats per Group)
Group
A WBI
B WBI (dexamethasone
treated)
C LTI
D LTI (dexamethasone
treated)
Mean Organ Weight (g)t
W1 (g) W2 (g) NL Lungs Spleen Thymus
62 110 48+9 0*95 0*38 0-25
(0*863) (0*345) (0-227)
59 76 50±8 0-66 0-17 0-09
(0*868) (0-223) (0-118)
61 113 22+6 0-92 0.51 0-21
(0-814) (0-451) (0-185)
59 80 4±1 0-64 0-37 0-06
(0-800) (0*462) (0-075)
* Groups A and C were injected with normal saline for 4 days.
t Specific organ weights (g/100 g body weight) shown in brackets.
TABLE VI.-Effect of Treatment of 6-week old Female Rats with 5 Daily Injections of
Mepyramine Maleate (40mg/kg), Hydrocortisone (20 mg/kg) or Dexamethasone (20
mg/kg) on Growth ofPrimary Tumour (Pr) and Pelvic Node Metastases (PN)pro4oced
by Intramuscular Injection of 107 Y-P388 Tumour Cells in the Right Leg. Half ofthe
Rats in Each Treatment Group were given 570 rad WBI 4 h before Injection ofTumour
Cells and Rats were Killed and Exsanguinated 5 Days Later to weigh Pr and PN and
measure the Haemoglobin (Hb) Concentration in the Tumours and Gain in Body Weight
(AW) after Irradiation* (6 Rats per Subgroup)
Treatment
WBI Drug
- (Saline)
+ (Saline)
- Mepyramine
+ Mepyramine
- Hydrocortisone
+ Hydrocortisone
- Dexamethasone
+ Dexamethasone
Tumour weight
(g)
AW PN/Pr
(g) Pr PN (x 10)
+15+1 1-84 0-12 0-65
±0-14 ±0-02
+3±1 2-41 0-30 1-24
+0-40 ±0-05
+18±1 1-71 0-13 0-76
+0-13 ±0-01
+8±2 2-38 0-28 1-17
±0-18 +0-04
+1+2 1-81 0-14 0-77
+0-27 ±0-02
-14+2 1-63 0-21 1-28
+0-12 ±0-05
-33±3 0-79 0-11 1-39
±0-10 ±0-03
-35±2 1-14 0-09 0-78
±0-06 ±0-01
Tumour Hb
concentration
(g g-I x lo-4
Pr PN
169 166
±20 ±20
149 195
±13 ±11
157 132
±16 ±16
164 187
±12 ±12
175 149
+13 ±12
261 267
±15 ±14
300 295
±29 ±55
335 412
±27 ±14
* Gain in body weight of untreated 6-week old female SPF rats is 3 - 5-4 g per day. In 6-week old rats
rate of growth after 570 rad WBI only is reduced to 12-15 g in 5 days (AW).
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after LTI, compared with l 00 cells when
irradiated rats are treated with DMZ
before the injection of tumour cells.
This reduction in CFE in irradiated lungs
by DMZ appears to be similar in magni-
tudeto that caused byDMZ inunirradiated
rats injected with 5 X 103 W-256 cells
(Table IV, Fig. 1).
Although DMZ failed to cure rats with
locally irradiated lungs and intravenously
injected with 102-104 W-256 cells, the
a
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FIG. 2. Suirvival of rats given 1000 rad LTI
(Day -7) after 102, 103 or 104 W-256 cells
were injected intravenously (Dav 0). 5 mg
DMZ/kg body weight (0) or isotonic saline
(0) injected intramuscularly on Days -5,
-4, -3 and -2. All deaths were due
to intrapleural haemorrhage from growth
of tumour in the lungs.
mean survival was increased by 2-3 days
(Fig. 2). W-256 cells double every 16-24
h in the lungs of the rat, so that this
increase in mean survival time agrees
well with the 5-10 fold reduction pro-
duced by DMZ in CFE for this tumour.
CFE in locally irradiated lungs and
kidneys of rats was also reduced by large
daily doses (15-20 mg/kg) of hydrocorti-
sone, whereas the mineralocorticosteroids
11-desoxycorticosterone and aldosterone,
failed to influence CFE (unpublished data).
Effect of steroids on growth ofprimiary
tumnour and metastases
Table VrI refers to the results of an
experiment in which primary tumours
were implanted in leg muscle by the
injection of 107 Y-P388 cells. It shows
the effects on growth of the primary
tumour implant (Pr) and of the pelvic
node metastases of treatment of immune-
intact or immunosuppressed rats with
large doses ofmepyramine, hydrocortisone
or dexamethasone. W;BI increased the
rates of growth of Pr and PN, but this
increase was reduced by the corticos-
teroids. Y-P388 tumour growth is
markedly haemorrhagic in character and
blood accounts for part of the tumour
weight, but it is seen that the degree of
tumour haemorrhage does not account for
the effect ofthesteroids on tumour growth;
tumours in dexamethasone-treated rats
contained more blood. The effect on
tumour growth of inhibition of growth of
animals by steroids in large doses may have
influenced the results. However, sub-
lethal WBI alone inhibited the growth of
rats; yet it stimulated tumour growth.
Both WBI and dexamethasone appeared
to promote spread of the tumour, as
indicated by approximately two-fold
increases in the ratio PN: Pr. However,
dexamethasone appeared to decrease
spread of tumour after WVBI. The
reasons for these changes produced in
the spread of tumours are obscure but
sufficiently important to warrant
further studies.
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Effect ofphenylbutazone on CFE
Stimulation of CFE by LTI was
significantly decreased by 2 doses of 100
mg phenylbutazone (PBZ), a non-steroidal
anti-inflammatory drug, given intramus-
cularly 24 and 8 h before the intravenous
injection of 103 W-256 tumour cells in
4-week old rats which had been given
1000 rad LTI 7 days previously; NL was
reduced from 52 ± 7 to 27 ± 7 by PBZ.
DISCUSSION
Adrenocorticosteroids are commonly
used in therapeutics to assist in preventing
host versus graft reactions when tissues
or organs are transplanted. Their mech-
anism of action in this context cannot be
attributed to a specific suppression of
cellular or other forms of immunity, and
any advantages from this therapy must
be due to suppression oflocalinflammatory
reactions to tissue damage which result
from immunological incompatibility or
some other cause (Goodman and Gilman,
1967). The anti-inflammatory potency
of dexamethasone is approximately 25
times that of hydrocortisone; essentially
it has no electrolyte regulating effects, as
distinct from mineralocorticosteroids such
as 1 -desoxycorticosterone and aldoste-
rone, which have little or no anti-inflam-
matory actions.
Our findings that large doses of anti-
inflammatory corticosteroids reduce the
take, growth and spread of allogeneic
tumour cells are clearly contrary to what
would be expected for an immunosup-
pressive action of these drugs; it is
reasonable to conclude that their inhibi-
tory effect is on the tumour bed and is
associated with their anti-inflammatory
action. It is possible that successful
implantation of a tumour cell in normal
tissue depends largely on the excitation
of a small local inflammatory response by
arrest of the cell. Inflammation rapidly
leads to regenerative growth ofthe stroma
(including blood vessels) and conceivably
provides a similar growth promoting
stimulus or support for the grafted cancer
cell. It is therefore significant that
steroids reduced the rate of growth of
primary implants and CFE in lungs in
unirradiated rats. We attribute the
increase of survival and clonogenic growth
of tumour cells effected by local and
whole body irradiation to a delayed
stimulation of the inflammatory process
produced by irradiation locally in the
target tissue, rather than to an immuno-
suppressive effect.
CFE in lungs for W-256 and Y-P388
tumours is very high and relatively few
cells are required to form colony forming
units which will produce progressive
growth in muscle or skin (van den Brenk
et al., 1973a). Consequently, progressive
growth is established very rapidly, before
transplantation immunity develops, which
once established would indeed prevent
further clonogenic growth and progressive
growth and spread of tumour. The rates
of trapping and disappearance from the
lungs of W-256 tumour cells, labelled with
1251-iododeoxyuridine in vitro and injected
intravenously have been monitored con-
tinuously in the rat by the radioactive
signal over the thorax: an onset of rapid
cell death occurred I h after the injection
in intact rats and 60% of the cells had
disappeared within the next 5 h, compared
with only 17% loss in rats given 1000 rad
LTI 7 days previously (unpublished data).
It is within 24 h after transplantation
that disorganization and inflammatory
reactions, induced in tissues of the host
by the arrest of tumour cells or as a result
oflocal irradiation ofthe implantation site
(tumour bed), seem to be of critical
importance in determining " take ", sur-
vival and clonogenic growth of tumour
cells. This is also the time when the
tumour-host relationship is most suscept-
ible to steroid therapy and before an
immune defence has developed.
Since this early steroid sensitive com-
ponent of allogeneic tumour-host com-
patibility is not attributed to immuno-
logical reactions, steroid therapy may be
of particular value in spontaneous cancers
in man to reduce the effect of radio-
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therapy of subsequently stimulating
growth of cancer cells deposited in
irradiated tissues, although some evidence
was obtained that steroids increased
exfoliation and dissemination (Table IV).
The dosage of dexamethasone required to
suppress tumour growth rapidly arrested
body growth of rats, but normal rate of
growth was re-established within 3-4 days
after the last dose. The finding that
phenylbutazone, anon-steroid anti-inflam-
matoryagent, alsoreducedtakeandgrowth
of tumour cells in irradiated lungs some-
what supports the hypothesis that inflam-
mation plays a local role in modulating the
take and growth of tumour cells in these
tissues.
We are deeply indebted to Dr H. B.
Hewitt for his generous advice and
invaluable help in preparing this paper.
We thank Mrs S. B. Duck for typing the
manuscript.
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